Revance Therapeutics, Inc. (NASDAQ:NASDAQ:RVNC) Q3 2022 Results Conference Call November 08, 2022 04:30 PM ET Company Participants Jessica Serra - Head of Investor Relations & ESG Mark.
PCI Pharma Services has added innovative, state-of-the-art equipment to its San Diego, Calif., and Melbourne, Australia, sites, enhancing its global offerings.